Antibody-based therapy: An alternative for antimicrobial treatment in the post-antibiotic era
- 15 November 2024
- journal article
- research article
- Published by Elsevier in Microbiological Research
- Vol. 290, 127974
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32172905)
This publication has 109 references indexed in Scilit:
- Computational strategies in Klebsiella pneumoniae vaccine design: navigating the landscape of in silico insights.Biotechnology Advances, 2024
- Rapid Diagnostics to Enhance Therapy Selection for the Treatment of Bacterial InfectionsCurrent Pharmacology Reports, 2023
- Nanobodies: Robust miniprotein binders in biomedicineAdvanced Drug Delivery Reviews, 2023
- Anti-bacterial monoclonal antibodies: next generation therapy against superbugsApplied Microbiology and Biotechnology, 2022
- Anti-drug antibodies in the current management of cancerCancer Chemotherapy and Pharmacology, 2022
- Current Stage in the Development of Klebsiella pneumoniae VaccinesInfectious Diseases and Therapy, 2021
- Is combined medication with natural medicine a promising therapy for bacterial biofilm infection?Biomedicine & Pharmacotherapy, 2020
- Non-traditional Antibacterial Therapeutic Options and ChallengesCell Host & Microbe, 2019
- Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn woundsBiologicals, 2017
- Therapeutic outcomes, assessments, risk factors and mitigation efforts of immunogenicity of therapeutic protein productsCellular Immunology, 2015